Saturday 17 October 2026
Export NSPR’s income statement to Excel — free account
InspireMD, Inc.
NSPR Healthcare Medical Devices
InspireMD, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.0 million, up 28.1% from fiscal 2024. In the quarter to June 2026, revenue was flat, EPS grew 34.6% and free cash flow fell 26.0%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.
0.46
0.02
−4.17%
Follow NSPR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 5 | 5 | 4 |
| (87.61%) | (106.88%) | (142.60%) | (202.81%) | ||
| (71.65%) | (83.96%) | (107.86%) | (134.60%) | ||
ROIC |
(4,122.45%) | (3,132.20%) | (1,591.72%) | (3,070.99%) | |
Return on Tangible Assets |
(73.36%) | (89.77%) | (119.88%) | (170.18%) | |
Average Days of Receivables |
114.30 | 104.39 | 93.81 | 81.07 | |
Free Cash Flow per Share |
(0.46) | (0.57) | (0.48) | (0.50) | |
Free Cash Flow |
(34.07) | (36.75) | (40.13) | (42.45) | |
Capital Expenditures |
(1.56) | (1.65) | (1.48) | (1.24) | |
| Other line items | |||||
Cash ROIC |
(26.72%) | (33.59%) | (47.11%) | (68.54%) | |
Accounts Receivable Turnover |
3.31 | 3.72 | 4.23 | 4.82 | |
Accounts Payable Turnover |
0.65 | 0.69 | 0.93 | 0.95 | |
Inventory Turnover |
1.93 | 2.12 | 2.66 | 3.09 | |
Average Days of Payables |
675.88 | 617.67 | 441.66 | 396.31 | |
Days of Inventory on Hand |
225.40 | 195.82 | 142.00 | 110.97 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
195.67% | 167.09% | 144.79% | 149.14% | |
Selling, General and Administrative Expense of Revenue |
432.11% | 414.97% | 363.84% | 362.95% | |
Share Based Compensation of Revenue |
152.08% | 137.34% | 107.93% | 98.84% | |
Operating CF/Net income |
0.70 | 0.72 | 0.75 | 0.79 | |
Depreciation/Fixed assets |
0.12 | 0.13 | 0.14 | 0.15 | |
Capex/Depreciation |
(3.82) | (3.46) | (2.81) | (2.14) | |
Revenue per Share |
0.11 | 0.14 | 0.13 | 0.13 | |
Operating CF per Share |
(0.44) | (0.55) | (0.46) | (0.49) | |
Capex per Share |
(0.02) | (0.03) | (0.02) | (0.01) | |
Capex to Sales |
0.20 | 0.18 | 0.14 | 0.11 |
Columns are period end dates